Literature DB >> 32201077

CSK promotes innate immune response to DNA virus by phosphorylating MITA.

Peng Gao1, Ming-Ming Hu1, Hong-Bing Shu2.   

Abstract

Upon detection of viral DNA, the cytoplasmic DNA sensor cyclic GMP-AMP (cGAMP) synthase (cGAS) utilizes GTP and ATP as substrates to synthesize the second messenger molecule 2'3'cyclic GMP-AMP (cGAMP), which binds to the ER-associated adaptor protein MITA/STING to signal innate antiviral response to DNA virus. How the cGAS-MITA pathways are post-translationally regulated is not fully understood. In this study, we identified the tyrosine kinase CSK as a positive regulator of cGAS-MITA mediated innate antiviral response. CSK-deficiency inhibits DNA virus-triggered induction of downstream antiviral effector genes. Following DNA virus infection, CSK phosphorylates MITA at Y240 and Y245, which is important for its activation. These results suggest that CSK plays a role in modulating innate immune response to DNA virus.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CSK; DNA virus; Innate immune response; MITA; Tyrosine phosphorylation

Mesh:

Substances:

Year:  2020        PMID: 32201077     DOI: 10.1016/j.bbrc.2020.03.069

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Post-Translational Modifications of STING: A Potential Therapeutic Target.

Authors:  Jiaqi Kang; Jie Wu; Qinjie Liu; Xiuwen Wu; Yun Zhao; Jianan Ren
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 2.  Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing.

Authors:  Kiramage Chathuranga; Asela Weerawardhana; Niranjan Dodantenna; Jong-Soo Lee
Journal:  Exp Mol Med       Date:  2021-11-16       Impact factor: 8.718

Review 3.  Insights on the cGAS-STING Signaling Pathway During Herpesvirus Infections.

Authors:  Lishuang Deng; Zhiwen Xu; Fengqin Li; Jun Zhao; Zhijie Jian; Huidan Deng; Siyuan Lai; Xiangang Sun; Yi Geng; Ling Zhu
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.